Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Seminars in Arthritis & Rheumatism

• Publication date

  1990-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0049-0172(90)90020-GPMID 2251508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gold salts in the treatment of rheumatoid arthritis. A double-blind study.

  2020cited by this paper
• Drug-induced pulmonary disease.

  2015cited by this paper
• The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis.

  1990cited by this paper
• Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.

  1990cited by this paper
• Does aggressive therapy of rheumatoid arthritis affect outcome?

  1989cited by this paper
• Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease.

  1989cited by this paper
• Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients.

  1989cited by this paper
• Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines.

  1989cited by this paper
• Combination methotrexate and sulfasalazine in the management of rheumatoid arthritis: case observations.

  1989cited by this paper
• Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.

  1989cited by this paper
• Honorable Justice: The Life of Oliver Wendell Holmes

  1989cited by this paper
• Remodeling the pyramid--a concept whose time has not yet come.

  1989cited by this paper
• Radiologic assessment as an outcome measure in rheumatoid arthritis.

  1989cited by this paper
• Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis.

  1989cited by this paper
• Advances in management of rheumatic disease. 1965 to 1985.

  1989cited by this paper
• Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.

  1989cited by this paper
• Parenteral gold therapy for rheumatoid arthritis: a treatment whose time has gone.

  1989cited by this paper
• Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.

  1989cited by this paper
• Lack of correlation between the Steinbrocker staging of hand radiographs and the functional health status of individuals with rheumatoid arthritis.

  1989cited by this paper
• Radiologic assessment as an outcome measure in rheumatoid arthritis.

  1989cited by this paper
• Parenteral gold therapy for rheumatoid arthritis: a treatment whose time has gone.

  1989cited by this paper
• Remodeling the pyramid--a concept whose time has not yet come.

  1989cited by this paper
• Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.

  1988cited by this paper
• A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months.

  1988cited by this paper
• Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.

  1988cited by this paper
• Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis.

  1988cited by this paper
• Survival in rheumatoid arthritis.

  1987cited by this paper
• Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study.

  1987cited by this paper
• Methotrexate in rheumatoid arthritis. Health and Public Policy Committee, American College of Physicians.

  1987cited by this paper
• Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis.

  1987cited by this paper
• Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial.

  1987cited by this paper
• Methotrexate therapy in rheumatoid arthritis. Current status.

  1986cited by this paper
• The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

  1986cited by this paper
• Impact of specific therapy upon rheumatoid arthritis.

  1986cited by this paper
• Efficacy of low-dose methotrexate in rheumatoid arthritis.

  1985cited by this paper
• Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1985cited by this paper
• Toxicity of low dose methotrexate in rheumatoid arthritis.

  1985cited by this paper
• HLA-DR genotype risks in seropositive rheumatoid arthritis.

  1984cited by this paper
• Small-vessel vasculitis and methotrexate.

  1984cited by this paper
• Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis.

  1983cited by this paper
• Radiographic evaluation of the course of articular disease.

  1983cited by this paper
• Low dose prednisone therapy in rheumatoid arthritis: a double blind study.

  1983cited by this paper
• Radiographic evaluation of the course of articular disease.

  1983cited by this paper
• Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis.

  1982cited by this paper
• [Follow-up study of patients with rheumatoid arthritis over a period of more than 10 years (1966-1978): analysis of disease progression and treatment in 100 cases (author's transl)].

  1981cited by this paper
• Penicillamine-induced "Goodpasture's syndrome": successful treatment of a fulminant case.

  1981cited by this paper
• Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals.

  1980cited by this paper
• Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals.

  1980cited by this paper
• Low dose pulse methotrexate therapy in rheumatoid arthritis.

  1980cited by this paper
• Low dose pulse methotrexate therapy in rheumatoid arthritis.

  1980cited by this paper
• Methotrexate induced liver cirrhosis

  1980cited by this paper
• Controlled trial of cyclophosphamide in rheumatoid arthritis.

  1976cited by this paper
• Diffuse pulmonary injury associated with gold treatment.

  1976cited by this paper
• Cyclophosphamide therapy and interstitial pulmonary fibrosis

  1976cited by this paper
• Letter: Moorgate tube disaster: disputed alcohol findings.

  1975cited by this paper
• Sulphasalazine induced lung disease

  1972cited by this paper
• A controlled trial of cyclophosphamide in rheumatoid arthritis.

  1970cited by this paper
• METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS.

  1964cited by this paper
• FINDINGS SUGGESTIVE OF A PULMONARY ALVEOLAR-CAPILLARY BLOCK SYNDROME IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA.

  1964cited by this paper
• Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists.

  1955cited by this paper

• Use of Complementary and Alternative Medicine among Osteoarthritic Patients: A Review.

  2016cites this paper
• Methotrexate in Rheumatoid Arthritis

  2012cites this paper
• Analysis of outpatient administration of methotrexate for rheumatoid arthritis treatment

  2009cites this paper
• Is low-dose methotrexate nephrotoxic? Case report and review of the literature.

  2005cites this paper
• A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM

  2004cites this paper
• Infiltrative lung disease due to noncytotoxic agents.

  2004cites this paper
• The treatment of rheumatoid arthritis.

  2004cites this paper
• Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis

  2003cites this paper
• Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents

  2002cites this paper
• Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment.

  2001cites this paper
• Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients.

  2000cites this paper
• Effects of methotrexate on normal articular cartilage in vitro and in vivo

  1998cites this paper
• E V ects of methotrexate on normal articular cartilage in vitro and in vivo

  1998cites this paper
• ects of methotrexate on normal articular cartilage in vitro and in vivo

  1998cites this paper
• Risk Factors for Methotrexate-Induced Lung Injury in Patients with Rheumatoid Arthritis: A Multicenter, Case-Control Study

  1997cites this paper
• Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.

  1996cites this paper
• Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.

  1996cites this paper
• Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial.

  1996cites this paper
• Adverse events in methotrexate-treated rheumatoid arthritis patients.

  1995cites this paper
• Advances and issues in the pharmacotherapy of rheumatoid arthritis

  1995cites this paper
• Methotrexate Management of Immune-Mediated Cochleovestibular Disorders

  1995cites this paper
• Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment.

  1995cites this paper
• Methotrexate in rheumatoid arthritis. An update.

  1994cites this paper
• Methotrexate therapy for autoimmune hearing loss: A preliminary report

  1994cites this paper
• A Risk-Benefit Assessment of Slow-Acting Antirheumatic Drugs in Rheumatoid Arthritis

  1994cites this paper
• Should methotrexate be used to treat early rheumatoid arthritis?

  1994cites this paper
• Aggressive therapy does not substantially alter the long-term course of rheumatoid arthritis. So what else is new?

  1993cites this paper
• Lack of immunosuppressive effect of low-dose oral methotrexate on lymphocytes in rheumatoid arthritis.

  1993cites this paper
• The effects of methotrexate on normal and osteoarthritic lapine articular cartilage.

  1993cites this paper
• [Present and future therapeutic strategies in rheumatoid arthritis].

  1993cites this paper
• Pancytopenia associated with low dose methotrexate therapy. A regional survey.

  1993cites this paper
• Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.

  1993cites this paper
• Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.

  1993cites this paper
• Low-dose methotrexate therapy for ocular inflammatory disease.

  1992cites this paper
• Changing perspectives in the treatment of rheumatoid arthritis.

  1992cites this paper
• Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.

  1992cites this paper
• [Therapeutic maintenance dose with methotrexate in rheumatoid polyarthritis. Prospective study of 191 cases].

  1992cites this paper
• Remission induction in rheumatoid arthritis.

  1992cites this paper
• Toxicity of antirheumatic medications in children with juvenile arthritis.

  1992cites this paper
• Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases.

  1992cites this paper
• Pharmacology and General Therapeutic Principles of Methotrexate

  1992cites this paper
• Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis

  1992cites this paper
• Diving injuries of the spinal cord.

  1992cites this paper
• Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia.

  1991cites this paper
• Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment.

  1991cites this paper
• arthritis . antirheumatic drugs ( SAARDs ) in rheumatoid Slow drugs : slow progress ? Use of slow acting

  year unknowncites this paper